Treatments
Toxicities
Types
MOA
Fun Facts
100

the preferred treatment for treating an HER2 negative disease consists of these regimens 

what is doxorubicin and cyclophosphamide followed by paclitaxel 

100

this is a major toxicity in the anthracyclines class 

what is cardiotoxicity 

100

this type of breast cancer usually has a delayed diagnosis due to it being presumed as cellulitis initial 

what is inflammatory 

100

this drug is an alkylating agent that cross links DNA strands therefore decreasing DNA synthesis by preventing cell division 

what is cyclophosphamide 

100

This type of cancer is the 2nd leading cause of cancer-related deaths in females

what is breast cancer 

200

the preferred treatment for HER2 positive consists of these 2 regimens 

what is paclitaxel and trastuzumab 

200

this CDK 4/6 inhibitor should be used in caution because it can prolong the QTc interval 

what is ribociclib 

200

this type of breast cancer has malignant appearing cells within ducts and lobules without actually invading the tissue 

what is non-invasive carcinoma (in-situ)

200

this drug class works by inhibiting DNA and RNA synthesis by inhibiting topoisomerase II and steric obstruction 

what is anthracyclines 

200

what percentage of patients will not have risk factors for breast cancer 

what is 60% 

300

a common toxicity of anthracyclines is extravasation, the treatment for this is

what is stop the infusion and apply ice 

300

this medication should not be used concurrently with doxorubicin due to an increased risk of cardiomyopathy 

what is trastuzumab 

300

this type of breast cancer is associated with heterogeneous groups of tumors that are usually adenocarcinomas and can be classified as IDC or ILC 

what is invasive carcinoma 

300

the MOA of this drug class works on microtubules to inhibit the depolymerization of tubulin  

what are taxanes 

300

this risk model is used as a tool to determine the % chance of developing breast cancer

what is the GAIL  risk model 

400

if a patient is premenopausal at diagnosis, this is the preferred regimen 

what is tamoxifen x 5 years +/- ovarian suppression/ablation 

400

endometrial cancer is more common in this selective estrogen receptor modulators 

what is tamoxifen 

400

this type of cancer, also known as DCIS, has not fully developed invasive in teh duct 

what is ductal carcinoma in situ 

400

this medication binds to the estrogen receptor and down regulates the expression of the receptor 

what is Fulvestrant 

400

the use of this drug class along with an anthracycline provides better outcomes 

what are taxanes 

500

if a patient is post-menopausal at diagnosis, this is the preferred treatment regimen  

what is an aromatase inhibitor x 5 years 

500

due to its potential to cause joint pain and bone density loss, this should be preformed at baseline and every 2 years to monitor bone mineral density 

what is a DEXA scan 

500

this type of cancer is a lesion caused by the production of solid cells within a breast lobule 

what is lobular carcinoma in situ 

500

exemestane is a steroidal this that works to prevent the conversion of androstenedione to estrone and testosterone to estradiol 

what is an aromatase inhibitor 

500

this percent of breast cancers are diagnosed even though there is no family history of breast cancer 

what is 85%

M
e
n
u